NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.210
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
NuCana Employees
As of December 31, 2023, NuCana had 28 total employees, including 25 full-time and 3 part-time employees. The number of employees decreased by 3 or -9.68% compared to the previous year.
Employees
28
Change (1Y)
-3
Growth (1Y)
-9.68%
Revenue / Employee
n/a
Profits / Employee
-$1,244,519
Market Cap
4.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Biomerica | 64 |
Sintx Technologies | 43 |
Predictive Oncology | 35 |
Healthcare Triangle | 31 |
FOXO Technologies | 29 |
Galmed Pharmaceuticals | 8 |
Protagenic Therapeutics | 3 |
GT Biopharma | 2 |
NCNA News
- 27 days ago - NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel - GlobeNewsWire
- 2 months ago - Baillie Gifford's Strategic Acquisition of NuCana PLC Shares - GuruFocus
- 3 months ago - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States - GlobeNewsWire
- 3 months ago - NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 - GlobeNewsWire
- 4 months ago - NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study - GlobeNewsWire
- 4 months ago - NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - NuCana to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire